美国食品和药物管理局限制新型COVID-19疫苗只适用于高风险群体,这一做法受到卫生专家的批评. FDA restricts new COVID-19 vaccines to high-risk groups, criticized by health experts.

美国食品和药物管理局限制了最新的COVID-19疫苗给那些有更高风险的并发症患者,引起了公共卫生专家的批评,他们认为这一举动不符合科学,可能限制疫苗的使用,可能增加住院和死亡. The FDA has restricted the latest COVID-19 vaccines to those at higher risk of complications, drawing criticism from public health experts who argue the move is unscientific and could limit vaccine access, potentially increasing hospitalizations and deaths. 主要医疗团体仍然建议为孕妇和幼儿接种疫苗。 Major medical groups still recommend vaccines for pregnant people and young children. 这些新的限制可能影响到保险的覆盖范围以及医生和药剂师获得疫苗的机会。 Insurance coverage and access to the vaccines from doctors and pharmacists may be affected by these new restrictions.